NCT01939886View on ClinicalTrials.gov

Treatment Efficacy and Malaria TRANSmission After Artemisinin Combination Therapy 2 (TRANSACT2)

PHASE3CompletedINTERVENTIONAL
Enrollment

219

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

November 30, 2013

Study Completion Date

November 30, 2013

Conditions
Malaria
Interventions
DRUG

Mefloquine - Artesunate

DRUG

Artemether-lumefantrine combination

Trial Locations (1)

40305

St. Jude's Clinic, ICIPE Thomas Odhiambo Campus, Mbita

All Listed Sponsors
collaborator

Kilimanjaro Christian Medical Centre, Tanzania

OTHER

collaborator

Radboud University Medical Center

OTHER

collaborator

European Union

OTHER

lead

London School of Hygiene and Tropical Medicine

OTHER

NCT01939886 - Treatment Efficacy and Malaria TRANSmission After Artemisinin Combination Therapy 2 (TRANSACT2) | Biotech Hunter | Biotech Hunter